Lomitapide
Juxtapid, Lojuxta (lomitapide) is a small molecule pharmaceutical. Lomitapide was first approved as Juxtapid on 2012-12-21. It is used to treat hypercholesterolemia in the USA. It has been approved in Europe to treat hypercholesterolemia. Juxtapid's patents are valid until 2027-08-19 (FDA).
| Trade Name | Lojuxta |
|---|---|
| Common Name | Lomitapide |
| Indication | hypercholesterolemia |
| Drug Class | Microsomal triglyceride transfer protein (MTP) inhibitors |
